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ABSTRACT 18 
During mitosis, eukaryotic cells must duplicate and separate their chromosomes in a 19 
precise and timely manner. The apparatus responsible for this is the kinetochore, which is 20 
a large protein structure that links chromosomal DNA and spindle microtubules to 21 
facilitate chromosome alignment and segregation. The proteins that comprise the 22 
kinetochore in the protozoan parasite Trypanosoma brucei are divergent from yeast and 23 
mammals and comprise an inner kinetochore complex comprising 24 distinct proteins 24 
(KKT1-23, KKT25) that include four protein kinases, CLK1 (KKT10), CLK2 (KKT19), 25 
KKT2 and KKT3. We recently reported the identification of a specific trypanocidal 26 
inhibitor of T. brucei CLK1, an amidobenzimidazole, AB1. We now show that chemical 27 
inhibition of CLK1 with AB1 impairs inner kinetochore recruitment and compromises 28 
cell cycle progression, leading to cell death. Here, we show that KKT2 is a substrate for 29 
CLK1 and identify phosphorylation of S508 by CLK1 to be essential for KKT2 function 30 
and for kinetochore assembly. Additionally, KKT2 protein kinase activity is required for 31 
parasite proliferation, but not for assembly of the inner kinetochore complex. We also 32 
show that inhibition or RNAi depletion of the Aurora kinase AUK1 does not affect CLK1 33 
phosphorylation of KKT2, indicating that AUK1 and CLK1 are in separate regulatory 34 
pathways.  We propose that CLK1 is part of a divergent signaling cascade that controls 35 







In eukaryotic cells kinetochores are large protein complexes that link chromosomes to 39 
dynamic microtubule tips, ensuring proper segregation and genomic stability during cell 40 
division. Several proteins tightly coordinate kinetochore functions, including the protein 41 
kinase Aurora Kinase B. The kinetochore has diverse evolutionary roots. For example, 42 
trypanosomatids, single cell parasitic protozoa that cause several neglected tropical 43 
diseases, possess a unique repertoire of kinetochore components whose regulation during 44 
cell cycle remains unclear. Here we shed light on trypanosomatid kinetochore biology, by 45 
showing that the protein kinase CLK1 coordinates the assembly of the inner kinetochore 46 
by phosphorylating one of its components, KKT2, allowing the timely spatial recruitment 47 
of the rest of the kinetochore proteins and posterior attachment to microtubules, in a 48 
process that is Aurora Kinase B independent. 49 
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At the onset of cell division, the accurate distribution of genomic material is crucial for 57 
cell survival and development (1). Central to this process are the kinetochores, a 58 
centromere macromolecular protein complex that drives chromosome segregation in 59 
eukaryotes by connecting chromosomes to microtubules (2). The kinetochore is a large, 60 
highly dynamic machine assembled from multiple pathways that are temporally 61 
controlled (3). Kinetochores gather on opposite sides of a centromere region of each 62 
chromosome where spindle microtubules attach (4). In general, the kinetochore can be 63 
thought of as a different set of proteins, assembled by timing blocks. The inner 64 
kinetochore, composed of proteins that bind to DNA or centromeric chromatin, is also 65 
known as the Constitutive Centromere-Associated Network (CCAN) in vertebrates and 66 
fungi (5). As a cell enters mitosis, outer kinetochore proteins are assembled on this 67 
platform of inner kinetochore proteins, forming the interaction surface for spindle 68 
microtubules, allowing chromosome movement (6). Several inner kinetochore 69 
components associate with kinetochores throughout the cell cycle, while other inner 70 
kinetochore proteins are recruited to the outer surface, specifically in mitosis (7). They 71 
provide a landing platform for the spindle assembly checkpoint (SAC) proteins, ensuring 72 
the fidelity of chromosome segregation (8).  73 
From yeast to humans, the majority of the CCAN assembly can be subdivided into four 74 
discrete units, and their stability depends critically on reciprocal interactions (6). 75 
Furthermore, the recruitment of components of the CCAN in these species depends on a 76 
specialized centromeric histone H3 variant, the centromere protein A (CENP-A) (9). The 77 
fact that some subunits are missing in certain lineages (10), highlights that much remains 78 
to be understood about the structural and functional contributions of these four CCAN 79 
complexes at the kinetochore. Functional studies indicate that the CCAN plays an active 80 
role in the efficient incorporation of CENP-A into centromeric nucleosomes (11), where 81 
afterwards, it is required either for the assembly of further kinetochore components thus 82 
functioning as a scaffold (2) or the regulation of kinetochore–microtubule dynamics (12). 83 
The emergence of eukaryotes from prokaryotic lineages has involved a significant rise in 84 
cellular complexity (13). Research on kinetochores has provided a picture of the essential 85 
organization of kinetochores across species. However, the functionality and dynamic 86 
organization of the layers that made the kinetochore in some early branch organisms, 87 
such as the kinetoplastids, remain unclear (14). This is the case of Trypanosoma brucei, 88 
the causative agent of Human African trypanosomiasis (HAT), whose kinetochore 89 
assembles from a repertoire of unique proteins very divergent from other organisms (15). 90 
To date, a trypanosomatid inner kinetochore which contains 24 unique proteins (KKT1-91 
23 and KKT25) has been identified (15, 16). Within this group, two proteins with protein 92 
kinase domains (KKT2-3) are constitutively localized to centromeres throughout the cell 93 
cycle, most likely acting as functional orthologues of the eukaryotic CCAN proteins (15, 94 
16). In addition, this parasite has a set of KKT-interacting proteins (KKIP1-12), which 95 
are related to outer kinetochore proteins Ndc80 and Nuf2 (17) and a cohort of proteins 96 
localized to the nucleus during interphase and to the spindle during mitosis (NuSAPs) 97 





Apart from KKT2 and KKT3, the T. brucei kinetochore contains two other protein 99 
kinases, CLK1 (KKT10) and CLK2 (KKT19) (15, 19). Previous studies have shown that 100 
CLK1 is essential for survival in the bloodstream form of this parasite (20, 21). As part of 101 
a drug discovery campaign, we recently identified the amidobenzimidazole AB1 as a 102 
trypanocidal covalent inhibitor of T. brucei CLK1. Detailed mode of action and target 103 
validation studies indicates that CLK1 is the main target of AB, which binds specifically 104 
to C215 residue at the hinge domain (22). Treatment of the bloodstream form with AB1 105 
caused nuclear enlargement during metaphase concomitant with a G2/M cell cycle arrest. 106 
Furthermore, we demonstrated that CLK1 inhibition impaired nuclear KKT2 distribution 107 
(22), suggesting that CLK1 has a role in kinetochore assembly or regulation. In the insect 108 
procyclic form KKT4 and KKT7 phosphorylation has been shown to depend on 109 
KKT10/19 and the localization of KKT10/19 is tightly controlled to regulate the 110 
metaphase to anaphase transition (19). Given the clinical importance of T. brucei 111 
bloodstream forms for drug intervention and the advantage of using a chemical tool to 112 
study the kinetochore regulation, here we demonstrate that CLK1 phosphorylates KKT2 113 
at S508 during early metaphase, and its inhibition affects the posterior recruitment of 114 
inner kinetochore components affecting chromosome segregation, in a pathway that is 115 
independent to Aurora Kinase B. 116 
 117 
RESULTS 118 
CLK1 inhibitor AB1 disrupts kinetochore dynamics in bloodstream form T. brucei. 119 
Given the importance of kinetochore movement during metaphase in eukaryotes (23), we 120 
assessed the impact of T. brucei CLK1 activity on kinetochore dynamics using AB1 as a 121 
chemical tool. The expression and localization of kinetochore proteins, labelled with 122 
mNeonGreen, were assessed by confocal microscopy in the bloodstream form of the 123 
parasite (Fig.1A). Similar to previous observations in procyclic form cells (15, 17), we 124 
observed different kinetochore timings and patterns of expression throughout the cell 125 
cycle. By using the kinetoplast (K) and nucleus (N) configuration to define each cell 126 
cycle stage (24), we observed that KKT2 and KKT3 are constitutively expressed until 127 
anaphase; KKT1 and KKIP1 gradually load from S phase onwards until the end of 128 
mitosis, whilst KKT4, KKT5 expression is restricted to metaphase. Furthermore, KKT9 129 
and KKIP7 expression diminish during anaphase, suggesting both proteins may be acting 130 
as scaffolds for the recruitment of multiple other components. Treatment with 5x EC50 of 131 
AB1 for 6 h caused dispersal, to varying degrees, for KKT1, KKT2, KKT5, KKT9, 132 
KKT13, KKT14 and KKT20 from the defined foci of the kinetochore within the nucleus, 133 
while KKT3, KKT7, KKT11, KKIP1 and KKIP7 remained in distinct foci (Fig. 1 B, C 134 
and Fig. S1 A). Automated foci detection using sub-pixel precise single particle 135 
localization combined with image segmentation (25) and intensity quantification (26) 136 
determined that there was a significant reduction in foci intensity for KKT1, KKT2, 137 
KKT4, KKT5 and KKT9, but not KKT3 (Fig. 1 D and Fig. S1B, C). No degradation of 138 
these proteins was observed after treatment (Fig S1 D). These results suggest that 139 
although KKT2 and KKT3 are centromere-anchored proteins (15), they respond 140 
differently to CLK1 inhibition and that TbCLK1 is a critical regulator of inner 141 





CLK1 phosphorylates KKT2 at position S508. 143 
KKT2 and KKT3 protein kinases are likely components of the trypanosome inner 144 
kinetochore with functional equivalence to the constitutive centromere-associated 145 
network (CCAN), a canonical component of the eukaryotic inner kinetochore (27). 146 
Defective KKT2 clustering was also observed after CLK1 RNAi (22). It has been 147 
reported that phosphorylation of kinetochore proteins has critical roles in kinetochore 148 
organization and interaction during mitosis in mammals and yeast (28). Indeed, cell cycle 149 
regulated changes in the phosphorylation of T. brucei kinetochore components have been 150 
reported recently, where the regulation is coordinated with phosphorylation of essential 151 
protein kinases including CLK1 (19). 152 
We speculated that KKT2 provides a platform on which the kinetochore multi-protein 153 
complex assembles, and that phosphorylation orchestrates this process. To address 154 
whether KKT2 might be a CLK1 substrate, we first analyzed mobility shifts of 155 
phosphorylated forms of KKT2 and KKT3 using Phos-tag™ gel electrophoresis (29). A 156 
low-mobility, non-phosphorylated form of KKT2 was detected after treatment with AB1 157 
or after CLK1 depletion by RNAi, whilst KKT3 remained unaffected (Fig. S2). Six 158 












) (30) and 159 
we tested if these are important for KKT2 function by generating a KKT2 RNAi line 160 
(Fig. S3) with a recoded HA-tagged version of KKT2 integrated into the tubulin locus. 161 
This constitutively expressed KKT2 (KKT2
R
) is not susceptible to RNAi-mediated 162 
degradation and KKT2
R
 complements the loss of function of KKT2 48 h after RNAi 163 









resulted in complementation of KKT2 function when expressed in the RNAi line. In 165 




 with Ala 166 
(KKT2
S507A-S508A
) failed to complement depletion of the wild type KKT2 with respect to 167 
parasite growth (Fig. 2B) or cell cycle progression after 48 h induction (Fig. 2C). The 168 
efficacy of RNAi knockdown of the endogenous KKT2 alleles was retained in these 169 
derivative cell lines (Fig. S3A,B,C) demonstrating that the complementation effects were 170 
imparted by the recoded alleles.  KKT2
S507A-S508A 
had good expression levels in the cell 171 
(Fig 2 B, lower panel), but was mislocalised (Fig. S3D), providing a possible explanation 172 
for the phenotype observed. These defects phenocopy the effect of AB1 and show the 173 
importance of the two phosphorylation sites for the function of KKT2. To assess whether 174 





). A significant loss of function was observed after 48 h induction, 176 
indicating protein kinase activity is essential for KKT2 function, but not for regulating 177 
cell cycle progression (Fig. 2B, C).  178 
To address whether CLK1 phosphorylates KKT2 directly at S
507-508 
residues, we 179 
expressed a recombinant peptide (aa 486 - 536) of KKT2 including mutations of S507 180 
and S508 residues. We demonstrated that recombinant CLK1 could phosphorylate 181 
recombinant KKT2 in vitro at positions S507-508 (Fig. 2D).  Given the conservation of 182 
KKT2 S
508 
in kinetoplastids, we then raised a phospho-specific antibody against 183 
KKT2
S508
 to follow KKT2 phosphorylation through the T. brucei cell cycle and after 184 









 was depleted following KKT2 or CLK1 RNAi (Fig. 2 E, 186 
upper panel), or after treatment with AB1 in a cell line where KKT2 was endogenously 187 
tagged with Ty and mNG (Fig. 2E, lower panel; both endogenous KKT2 and Ty-mNG 188 
KKT2 are detected). In addition, the KKT2 phosphoantibody detects phosphorylated 189 
KKT2 in all the recoded mutants, except the KKT2
S507A-S508A 
double mutant (Fig. S3E). 190 
KKT2
S508
 phosphorylation was found to increase in S-phase after hydroxyurea 191 
synchronization and progressively decrease towards G1-phase (Fig. 2F), in correlation 192 
with the recent demonstration of dynamic KKT2 S508 phosphorylation during the cell 193 
cycle (31). Together, these data show that KKT2 phosphorylation is downstream of 194 
CLK1 in a kinetochore-specific signaling cascade and occurs during early metaphase.  195 
We next assessed whether KKT2 phosphorylation is required for recruitment of proteins 196 










induced line (Fig. S4A) underlining the importance of KKT2 phosphorylation by CLK1 199 





impaired KKT1 and KKT9 recruitment, but also affected the timing of events during 201 
mitosis, with a notable defect in nuclear abscission (Fig. S4B). 202 
CLK1 and AUK1 are not part of the same signaling pathway. 203 
Faithful chromosome segregation relies on the interaction between chromosomes and 204 
dynamic spindle microtubules (32). Furthermore, spindle elongation is important for 205 
correct segregation of chromosomes during anaphase (33). To further examine if CLK1 206 
inhibition impairs microtubule spindle dynamics, we observed the expression of the 207 
mitotic spindle by staining the parasites with KMX-1 antibody and analyzing the 208 
microtubule-associated protein 103 kDa (MAP103) (Fig. S5) (34), this showed that 209 
treatment with AB1 does not affect microtubule spindle formation (Fig. 4 A). Considering 210 
that CLK1 inhibition during metaphase results in an arrest in late anaphase (19, 22), it is 211 
likely that the function of CLK1 during cytokinesis is related to either the control of 212 
kinetochore-spindle microtubule attachment errors, or its interactions with the 213 
chromosomal passenger complex (CPC). Of note, it has been reported that T. brucei 214 
aurora kinase B has an important role during metaphase-anaphase transition and the 215 
initiation of cytokinesis via regulation of the CPC (35–37) and nucleolar and other 216 
spindle-associated proteins (NuSAPs) (38). 217 
In mammals, kinetochore assembly is enhanced by mitotic phosphorylation of the Dsn1 218 
kinetochore protein by aurora kinase B, generating kinetochores capable of binding 219 
microtubules and promoting the interaction between outer and inner kinetochore proteins 220 
(39). In T. brucei, aurora kinase B (TbAUK1) plays a crucial role in spindle assembly, 221 
chromosome segregation and cytokinesis initiation (37). Therefore, we asked if CLK1 222 
and AUK1 are part of the same signaling pathway. We showed that treatment with AB1 223 
does not affect spindle formation (Fig. 4 A), in contrast to the inhibition of AUK1 (40). 224 
AUK1 is a key component of the trypanosome CPC (41). To understand if CPC 225 
dynamics are impaired by CLK1 inhibition, we followed the localization of CPC1 226 





by Hesperadin (42). After treatment with AB1, CPC1 showed a dispersed nuclear pattern 228 
that progressively disappeared after abscission of the nucleus (Fig. 4 B middle). This was 229 
different from AUK1 inhibition by Hesperadin, which prevented trans-localization of the 230 
CPC from the spindle midzone, impairing initiation of cytokinesis (Fig. 4 B right). 231 
Finally, we confirmed that AUK1 is not involved in kinetochore assembly since neither 232 
KKT2
S508
 phosphorylation nor KKT2 localization was affected by AUK1 inhibition by 233 
Hesperadin (Fig. 4 C). In addition, a cohort of divergent spindle-associated proteins have 234 
been described that are required for correct chromosome segregation in T. brucei (18). 235 
Therefore, we analysed the subcellular localizations of NuSAP1 and NuSAP2 during the 236 
cell cycle after CLK1 inhibition. NuSAP2 expression in the central portion of the spindle 237 
after metaphase release was compromised by CLK1 inhibition, whilst NuSAP1 remained 238 
unaffected (Fig. 4 D). NuSAP2 is a divergent ASE1/PRC1/MAP65 homolog, a family of 239 
proteins that localizes to kinetochore fibres during mitosis, playing an essential role in 240 
promoting the G2/M transition (43). Considering that NuSAP2 and KKT2 co-localise 241 
during interphase and metaphase (18), it is likely that KKT2 regulation by CLK1 242 
influences posterior spindle stability and cytokinesis. 243 
 244 
DISCUSSION 245 
The inner kinetochore complex of T. brucei is unusual in that none of the 24 identified 246 
KKT proteins have any sequence identity with CENP proteins of the Constitutive 247 
Centromere-Associated Network (CCAN) in yeast or vertebrates (15, 16).  Four of the 248 
KKTs contain protein kinase domains and here we provide the first evidence of a unique 249 
protein kinase signaling pathway that regulates inner kinetochore function in bloodstream 250 
form T. brucei. KKT2 is a multi-domain protein, constitutively associated with the 251 
centromere during the cell cycle, which contains an N-terminal protein kinase domain, a 252 
central domain with a unique zinc finger domain and a C-terminal divergent polo box 253 
domain (PDB) (15). The PBD and the central domain are sufficient for kinetochore 254 
localization (44), but it is not clear if KKT2 binds directly to DNA or forms a protein 255 
complex at nucleosomes with other KKT proteins.  In this study, we show that whilst 256 
KKT2 protein kinase activity is required for growth and replication of bloodstream form 257 
trypanosomes (Fig. 2 B), the localization of KKT1 and KKT9 to the kinetochore 258 
remained unaffected by the loss of KKT2 protein kinase activity (Fig. S4A). These data 259 
suggest that KKT2 protein kinase activity is required for a function of the kinetochore 260 
that is independent from assembly of its inner complex. 261 
We also show that phosphorylation of the kinetochore, and specifically KKT2, is crucial 262 
for kinetochore assembly in bloodstream form T. brucei.  Depletion of the kinetochore 263 
protein kinase CLK1 (KKT10) by RNAi, or inhibition with the CLK1 inhibitor AB1 is 264 
lethal due to disruption of kinetochore assembly (22).  Multiple phosphorylation sites 265 
have been identified in KKT2 and a number are cell cycle regulated, including S508 (31), 266 
suggesting a regulatory role.  Whilst we cannot discount phosphorylation of S507 or 267 
other sites as a requirement for kinetochore assembly, we only identified S508 to be 268 
essential, indicating that the other known phosphorylation sites cannot compensate for 269 
loss of phosphorylation on S508.  S508 is located between the Cys-rich central domain 270 





with chromatin via its DNA binding domain. Indeed, the finding that KKT2
S507A-S508A
 is 272 
mislocalised supports this hypothesis and the fact that the mutant protein can localise to 273 
the kinetochore in the presence of wild type KKT2 suggests that KKT2 is an oligomer 274 
and that the WT protein can recruit and retain the mutant protein on the kinetochore. As 275 
KKT2 protein kinase activity is not required for assembly of the kinetochore, 276 
phosphorylation of S508 seems less likely to regulate the kinase activity of KKT2.  277 
By using chemical and molecular approaches, we demonstrate that phosphorylation of 278 
KKT2 in the bloodstream form during metaphase allows the spatial recruitment of inner 279 
kinetochore components. We provide evidence that KKT2 is phosphorylated by CLK1, 280 
but we cannot formally rule out the possibility of an intermediate kinase being involved. 281 
Recently, a study showed that in the procyclic form CLK1 kinase activity is essential for 282 
metaphase to anaphase transition, although its expression was dispensable for the 283 
recruitment of kinetochore components (19). This difference may be due to cell cycle 284 
regulators having different functions in the two developmental stages of T. brucei (45, 285 
46), or because there can be protein turnover differences between life cycle stages (47). 286 
Indeed, CLK1 protein expression relative to CLK2 appears higher the bloodstream 287 
trypanosome (22) than the procyclic form (19). 288 
 289 
In T. brucei bloodstream forms, we show that KKT2 is a substrate for CLK1. In 290 
mammals CLK protein kinases are found in the cytoplasm and in the nucleus, where they 291 
regulate alternative splicing through phosphorylation of serine/arginine-rich domains on 292 
splicing factors (48), as occurs with human CLK1 in association with the serine-arginine 293 
protein kinase 1 (SRPK1) (49). Human CLKs also activate the abscission checkpoint in 294 
human cells by phosphorylating Aurora Kinase B, most likely acting as upstream 295 
regulators (50). The role of CLKs in regulating splicing is conserved across many 296 
organisms, including Plasmodium falciparum, where inhibition of PfCLK1-3 is lethal to 297 
the parasite by preventing the splicing of essential genes (51). In T. brucei most genes are 298 
constitutively transcribed as polycistronic mRNAs that are resolved through trans-299 
splicing (52), but it remains unclear if CLK1 also has a role in that process. It has been 300 
proposed that the unique domains structure of T. brucei kinetochore proteins is consistent 301 
with the T. brucei kinetochore having a distinct evolutionary origin (15, 44) and the 302 
finding of a unique CLK1/KKT2-centred regulation for kinetochore assembly supports 303 
that hypothesis. 304 
 305 
As with most signaling networks, phosphorylation plays an essential role in the 306 
regulation of kinetochore functions, and multiple kinases have been found to regulate 307 
kinetochores (53). Key examples are Aurora kinase B, MPS1, BUB1, PLK1, and CDK1 308 
(53, 54). From yeast to humans, most of the functions of Aurora kinase B require its 309 
incorporation into the CPC (55), and its dynamic localisation during the cell cycle (54). 310 
As a regulator of the kinetochore-microtubule attachment during mitosis, Aurora Kinase 311 
B contributes decisively to two feedback mechanisms, the error correction (EC) and 312 
spindle assembly checkpoint (SAC) (56). Furthermore, it promotes the inner and outer 313 
kinetochore interactions through phosphorylation of Dsn1 (39, 57, 58), a subunit of the 314 





Aurora Kinase B orthologue, TbAUK1, has distinctive roles in metaphase-anaphase 316 
transition, ensuring a proper spindle assembly, chromosome segregation as well as 317 
cytokinesis (37, 40). Alongside the parasite CPC, TbAUK1 associates with chromosomes 318 
during G2/M phase, and with kinetochores in metaphase, and finally localizes in the 319 
spindle midzone in anaphase (41), suggesting a possible role coordinating kinetochore 320 
recruitment and attachment. However, the potential role of this kinase in promoting 321 
kinetochore assembly has not yet been established or well separated from its regulatory 322 
function on mitosis. 323 
In the T. brucei procyclic form, two kinetochore proteins, KKT4 and KKIP4, localize to 324 
the spindle during mitosis (17, 60). Our results suggest that localization/expression of key 325 
outer kinetochore proteins remains unaffected after CLK1 inhibition, whereas KKT4, 326 
recently described as a microtubule tip–coupling protein (60), remains in anaphase, 327 
suggesting end-on interaction defects of microtubules with kinetochores. The role of 328 
Aurora kinase B in the interaction of the inner and outer kinetochore interaction in yeast 329 
resembles our findings of TbCLK1 functions in the recruitment of inner kinetochore 330 
during metaphase. Conversely, our results indicate that both pathways act independently 331 
in T. brucei, or at least not involving inner plate recruitment through KKT2 332 
phosphorylation, the stability of KKT2 localisation further support this hypothesis. 333 
Interestingly, inhibition of CLK1 affects CPC localisation at metaphase, and NuSAP2 334 
during anaphase.  Understanding that centromeric localization of CPC is required to 335 
correct errors in attachment (61), and NuSAPs stabilizes kinetochore microtubule during 336 
metaphase (62), it will be possible that during anaphase onset, CLK1 and TbAUK1 337 
coordinates different layers of regulation of kinetochore microtubule attachment and 338 
spindle stabilisation. The fact that CLK1 co-purifies with TbMlp2 and NuSAP1, provides 339 
further support for this (18). Interestingly, NuSAP1-4 partially co-localises with KKT2 (a 340 
CLK1 substrate) during the cell cycle, and knockdown of NuSAP1 destabilizes the 341 
expression of KKT1, but also triggers an unequal nuclear division without affecting 342 
spindle assembly (18), similar to our findings with KKT2 phosphomutants. Future 343 
experiments are required to determine whether the CLK1-KKT2 axis regulation of inner 344 
kinetochore assembly in T. brucei, also requires a specific set of NuSAPs proteins. 345 
Altogether, we propose a model where CLK1 progressively phosphorylates KKT2 during 346 
S phase, allowing the timely spatial recruitment of the rest of the kinetochore proteins 347 
and posterior attachment to microtubules (Fig. 5).  It is possible that KKT2 is 348 
phosphorylated by CLK1 prior to recruitment to the kinetochore, but evidence suggests 349 
this would occur during early S-phase (32). Inhibition of CLK1 activity with AB1 leads 350 
to impaired inner kinetochore assembly and irreversible arrest in M phase, suggesting 351 
that this defect cannot be repaired by the parasite’s checkpoint control, implying a dual 352 
function of CLK1 at different points during chromosome segregation. Considering the 353 
conservation of CLK1 between T. brucei, T. cruzi and L. mexicana (22), the bioactivity 354 
of AB1 against the three trypanosomatids and the conservation of KKT2 S508 355 
phosphorylation site in Leishmania and T. cruzi, it is quite likely that this signaling 356 
pathway is conserved across the trypanosomatids. 357 
 358 






Parasites. All transgenic T. b. brucei parasites used in this study were derived from 361 
monomorphic T. b. brucei 2T1 bloodstream forms (63) and were cultured in HMI-11 362 
[HMI-9 (GIBCO) containing 10% v/v foetal bovine serum (GIBCO), Pen/Strep 363 
solution (penicillin 20 U ml−1, streptomycin 20 mg ml−1)] at 37 °C/5% CO2 in vented 364 
flasks. Selective antibiotics were used as follows: 5 μg ml−1 blasticidin or hygromycin 365 
and 2.5 μg ml−1 phleomycin or G418. RNAi was induced in vitro with tetracycline 366 
(Sigma Aldrich) in 70% ethanol at 1 μg ml−1. Endogenous Ty, mNeonGreen  was 367 
performed using the pPOTv6 vector  (64) The generation of inducible TbCLK1 and 368 
KKT2 RNAi was generated as previously described (20).  369 
 370 
Plasmids. Recoded KKT2 was synthesized by Dundee Cell Products. The recoded KKT2 371 
sequence (KKT2
R
) codes for the same amino acid sequence as KKT2 but only shares 372 
94.23% nucleotide identity. All segments of identity between KKT2 and KKT2
R
 are less 373 
than 20 base pairs long. KKT2
R
 was inserted into the plasmid pGL2243 using XbaI and 374 
BamHI restriction sites, generating pGL2492. This plasmid is designed to constitutively 375 
express KKT2 from the tubulin locus, with the addition of a C-terminal 6x HA tag. To 376 













) were changed to alanine by mutating pGL2492, 378 
carrying the coding sequence for KKT2, using site directed mutagenic PCR. A list of 379 
primers is provided in Supplementary Methods. To generate individual KKT2 recoded 380 
mutants, correspondent KKT2
R
 plasmids (above) were transfected into the KKT2 RNAi 381 
cell line. Localization of endogenous KKT1 and KKT9 in KKT2
R
 mutants were assessed 382 
by microscopy after transfection of the correspondent mNG-KKT1 or mNG-KKT9 383 
pPOTv6 vector into each recoded cell line.  384 
 385 
Immunofluorescence and cell cycle analysis. Cells treated for 6 hours with compounds 386 
or DMSO were centrifuged at 1400 g for 10 min before washing twice with TDB-glucose 387 
at room temperature. Suspensions were centrifuged at 1000 g for 5 min and pipetted into 388 
6-well microscope slides and dried at RT. Cells were fixed with 25µl of 2% 389 
paraformaldehyde diluted in PBS and incubated at room temperature for 5 min. Cells 390 
were washed in PBS to remove paraformaldehyde prior to washing twice more with PBS 391 
and permeabilized with 0.05% NP40 for 10 min. Cells were washed twice in PBS and 392 
dried at RT. Mounting media with DAPI was added to each well with a coverslip. Slides 393 
were kept at 4 
o
C before viewing using a Zeiss LSM 880 with Airyscan on an Axio 394 
Observer.Z1 invert confocal microscope. 395 
Ty-NuSAP1 and Ty-NuSAP2 were detected by indirect immunofluorescence by using a 396 
mouse Imprint ® Monoclonal Anti-Ty1 antibody (clone BB2). Briefly, cells were 397 
harvested by centrifugation at 1400 g for 10 min at room temperature, washed, and 398 
resuspended in TDB-glucose. 2x10
5
 cells were dried on slides, fixed in 1% 399 
paraformaldehyde (PFA) for 1 hr, washed with PBS, blocked with 50% (v/v) foetal 400 
bovine serum for 30 min and then incubated with anti-TY (1:800) diluted in 0.5% 401 







). Cells were DAPI stained and visualized using a Zeiss LSM 880 403 
with Airyscan on an Axio Observer.Z1 invert confocal microscope.  404 
To study the spindle formation, wild type bloodstream forms were treated or not for 6 h 405 
with AB1 (5x EC50) or CLK1 RNAi cells treated or not with tetracycline for 24 h. 406 
Parasites were harvested by centrifugation at 1,400g for 10 min and then washed twice 407 
with Trypanosoma dilution buffer (TDB)-glucose at room temperature. Samples were 408 
fixed for 10 min in 2% w/v formaldehyde in PBS, followed by 5 min incubation with 1M 409 
Tris pH 8.5 to quench the fixation. The fixed cells were washed with PBS, suspended in 410 
PBS, and adhered to SuperFrost Plus™ Adhesion slides for 15 min. Attached parasites 411 
were then permeabilized with methanol at -20ºC for 15 min and rehydrated with PBS 412 
followed by incubation with blocking buffer (5% bovine serum albumin, 0.1% Triton X-413 
100 in PBS) for 1 h at room temperature. Cells were immunostained at room temperature 414 
for 1 h with KMX-1 antibody to detect the mitotic spindle.  After three washes (0.1% 415 
Triton X-100 in PBS), samples were incubated for one hour with an Alexa Fluor 488-416 
conjugated goat anti-mouse IgG (used at 1:300) secondary antibody. Finally, after three 417 
more times washes, the slides were mounted in ProLong™ Diamond Antifade Mountant 418 
with DAPI and examined by fluorescence microscopy. For analysis, 2K1N and 2K2N 419 
populations (n=80) were considered, and statistical significance determined using the 420 
Holm-Sidak t- test, with alpha = 0.05.  421 
For cell cycle analysis, bloodstream form T. brucei cell lines were incubated or not for 6 422 
h with AB compounds at a final concentration of 5X the individual EC50 value for each 423 
compound (averaged from viability assays). Control cultures were treated with 0.5µl 424 
DMSO. Cultures were pelleted and cells were collected and washed once in 425 
Trypanosoma dilution buffer (TDB) supplemented with 5 mM of EDTA and resuspended 426 
in 70% methanol. Cells were centrifuged at 1400 g for 10 min to remove methanol and 427 
washed once in TDB 1x with 5mM EDTA. Cells were resuspended in 1ml TDB 1x with 428 
5mM EDTA, 10µg ml
-1
 of propidium iodide and 10µl of RNase A. Cell suspensions in 429 
1.5 ml tubes were wrapped in foil to avoid bleaching by light. Cells were incubated for 30 430 
min at 37°C in the dark until FACS analysis. Cells were analyzed for FACS using a 431 
Beckman Coulter CyAn ADP flow cytometer (excitation; 535, emission; 617). Cell cycle 432 
phase distribution was determined by fluorescence. 433 
 434 
Hydroxyurea-induced synchronization of cell lines was obtained by incubating parasites 435 
in exponential growth phase with 10 µM of Hydroxyurea (HU) (Sigma Aldrich) for 6 hr. 436 
Removal of HU from the culture medium was achieved by centrifuging cells at 1400 g 437 
for 10 min, washing twice with fresh (drug free) medium and resuspending cells in 438 
medium lacking HU. Subsequently, samples were collected each hour for posterior cell 439 
cycle analysis by propidium iodide staining.  440 
 441 
Protein analysis. KKT2 and KKT3 phosphorylation profile were analyzed by using a 442 
SuperSep Phos-tag™ Precast Gel (29) according to the manufacturing protocol. Briefly, 443 
Ty-mNG KKT2 and Ty-mNG KKT3 were incubated with 5x AB1 EC50 for 18 hr and 444 
collected for analysis by WB in an EDTA-free RIPA lysis buffer. In parallel, the 445 





electrophoresis, the gel was washed 5 times with 10 mM EDTA transfer buffer to 447 
improve transference. Then, the membrane was transferred to a PVDF membrane using a 448 
0.1% SDS Tris-Glycine transfer buffer at 90 mA overnight at 4 
o
C. The membrane was 449 
blocked for 1 hour with 10% BSA and KKT2 and KKT3 phosphorylation pattern was 450 
analyzed by using an anti-Ty1 antibody (see Supplementary Methods for details). 451 
Anti-phospho KKT2 S
508 
was raised against a synthetic phosphopeptide antigen C-452 
GTRVGS(pS*)LRPQRE-amide, where pS* represent phosphoserine. The peptide was 453 
conjugated to keyhole limpet hemocyanin (KLH) and used to immunize rabbits. 454 
Phosphopeptide-reactive rabbit antiserum was first purified by protein A 455 
chromatography. Further purification was carried out using immunodepletion by non-456 
phosphopeptide resin chromatography, after which the resulting eluate was 457 
chromatographed on a phosphopeptide resin. Anti-antigen antibodies were detected by 458 
indirect ELISA with unconjugated antigens passively coated on plates, probed with anti-459 
IgG-HRP conjugate, and detected with ABTS substrate. Posterior antigen specificity was 460 
confirmed by western blot using KKT2 RNAi and endogenous tagged KKT2 cell lines. 461 
Custom antibody was produced by Thermo Fisher Scientific. 462 
 463 
For Western blotting parasites were washed with trypanosome dilution buffer (TDB) 464 
supplemented with 20 mM of glucose. After centrifugation, the samples were 465 
resuspended in the RIPA buffer (New England Biolabs, #9806S)) supplemented with 466 
protease and phosphatase inhibitors obtained from Promega and Roche Life Science 467 
respectively. All samples were quantified by Bradford protein assay (Bio-Rad), 25 µg of 468 
protein was loaded, resolved in a 4-20% NuPAGE Bis‐Tris gel (Invitrogen) in NuPAGE 469 
MOPS running buffer and transferred onto Hybond‐C nitrocellulose membranes (GE 470 
Healthcare) at 350 mA for 2 h or, for high molecular weight proteins, overnight at 4 
o
C. 471 
After transfer, membranes were washed once in 1x TBST (tris-buffered saline (TBS), 472 
0.01% Tween-20 (Sigma Aldrich)) for 10 min then incubated for 1 hour in blocking 473 
solution (1x TBST, 5% BSA) or, if required, overnight at 4 
o
C. Next, the membrane was 474 
rinsed for 10 min in 1X TBST and placed in blocking buffer containing the required 475 
primary antisera for 1 hour at room temperature or overnight at 4 
o
C. The membrane was 476 
then washed 3 times with TBST and placed in blocking solution containing the 477 
appropriate fluorescent secondary antisera for 1 hr. A list of antibodies is provided in 478 
Supplementary Methods. 479 
General Statistics. 480 
All statistical analysis was performed using GraphPad Prism 8 481 
(http://www.graphpad.com/scientific-software/prism/). The appropriate tests were 482 
conducted and are as detailed in the corresponding figure legends. 483 
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Figure 1. CLK1 inhibition impairs inner kinetochore dynamics. (A) Scheme of the 656 
kinetochore assessment workflow by immunofluorescence. A representative cohort of 657 
kinetochore components were endogenously labelled with mNeonGreen (mNG) in T. 658 
brucei bloodstream forms. Fixed parasites in metaphase or anaphase were considered for 659 
analysis of kinetochore pattern and intensity. (B) Localization of inner (top panel) and 660 
outer (lower panel) kinetochore core components after CLK1 inhibition by AB1. 661 
Parasites were incubated or not for 6 hr with 5x EC50 AB1. Representative fluorescence 662 
microscopy micrographs, showing bloodstream form parasites endogenously expressing 663 
N-terminal mNeonGreen (mNG) tagged kinetochore proteins. Cells with 2K1N and 664 
2K2N kinetoplast/nucleus configuration are shown. Cells were counterstained with DAPI 665 
to visualize DNA (cyan). The right panel shows the Nomarsky (DIC) corresponding 666 
images. Scale bar, 2µm. (C) Percentage of cells in metaphase (1N2K) and anaphase 667 
(2N2K) showing a defined kinetochore localization before and after AB1 treatment as in 668 
(a) (n>100 cells in each stage).  (D) Intensity of KKT foci detected before (DMSO) and 669 
after AB1 treatment. The data represents 75% percentile of total foci intensity (n=80 670 
kinetochores in each condition). Error bars, SEM; ** p<0.01, ***p < 0.001.  ns not 671 
significant. (Mann–Whitney U test).  672 
Figure 2. CLK1 regulates KKT2 function by phosphorylation of S508.  673 
(A) Schematic representation showing known KKT2 phosphosites and phosphomutants.  674 




phosphomutants and 675 
active site mutant. Bars showing cumulative fold over uninduced control counts over 676 
time following tetracycline induction of cell lines in culture. Error bars represent mean ± 677 
SEM of three replicates; P values were calculated using a Two-tailed Student’s t-tests; 678 
where ** p<0.01, ***p < 0.001. Lower panel:  Western blot of HA-KKT2 mutants. The 679 
expression of KKT2 phosphomutants mutants were detected using an anti-HA antibody. 680 





phosphomutants. Bars showing G2/M ratio over 682 
uninduced control following tetracycline induction of cell lines in culture. Error bars 683 
represent SEM of 3 replicates. P values were calculated using a Two-tailed Student’s t-684 
tests; where ***p < 0.001. (D) Recombinant CLK1 (rCLK1) phosphorylates recombinant 685 




) was 686 
used as substrate for rCLK1 by ADP-Glo™ Kinase Assay. The same fragment but 687 
including a S
507A-S508A 
mutation (blue) was used as a control. Phosphorylation of maltose 688 
binding protein (MBP) and rCLK1 autophosphorylation (no substrate) was included as 689 
control. Error bars, SEM (n=3); ***p < 0.001 (Two-tailed Student’s t-test). Conservation 690 
of amino acids surrounding KKT2 S507-508 in T. brucei (tb), T. cruzi (tc) and L. 691 
mexicana (lm) is shown to the right. (E) Specificity of KKT2 S
508
 phospho-specific 692 
antibody. Top: CLK1 and KKT2 RNAi was induced in 2T1 parasites for 24 hr. KKT2 693 
phosphorylation was analyzed by western blot using KKT2 S
508
 phospho-specific 694 
antibody Bottom: Phosphorylation of KKT2 S
508
 and Ty-mNG KKT2 S
508
 after 18 hr 695 
treatment with 5x EC50 AB1. EF-1 alpha protein expression was used as the loading 696 
control. (F) KKT2 S
508
 phosphorylation during the cell cycle. Cells expressing Ty-mNG-697 
tagged KKT2 were synchronized in late S phase by incubating with 10 µM hydroxyurea 698 







 phosphorylation was analyzed by western blot. Cell cycle progression was assessed 700 
by flow cytometry (left) by staining with propodium iodide. Data is representative of two 701 
biological replicates. 702 
Figure 3. Phosphorylation of KKT2 is required for kinetochore assembly.  703 
(A) Schematic representation showing the endogenous labelling of KKT1 or KKT9 in 704 
KKT2 recoded S507-508 phosphomutant. (B) Recruitment of KKT1 and KKT9 to the 705 




 mutant. Representative fluorescence 706 
microscopy of BSF parasites endogenously expressing KKT1 or KKT9 tagged with 707 





 mutant. Cells were counter stained with DAPI to visualize DNA (cyan). 709 
Scale bar, 2µm. (C) Regulation of KKT1 and KKT9 in recoded KKT2 S507-508A 710 
parasites. Top: Expression of the recoded HA-KKT2 S507-508A mutant detected by 711 
Western blot using anti-HA antibody. EF-1 alpha protein expression was used as the 712 
loading control. Bottom: Intensity of mNG-KKT1 and mnG-KKT9 foci in recoded KKT2 713 
S507-508A mutants. The data represents 75% percentile of total foci intensity (n>25 714 
kinetochores in each condition). Error bars, SEM; ***p < 0.001 (Mann–Whitney U test). 715 
Figure 4. Localization of CPC1 after treatment with AB1 or Hesperadin.  716 
(A) Spindle formation after CLK1 inhibition or RNAi knockdown. Top panel: Parasites 717 
were left untreated or treated for 6 hr with 5x EC50 AB1 and analyzed by confocal 718 
microscopy. Bottom panel:  CLK1 was depleted by RNAi for 24 hr after addition of 719 
tetracycline and compared with the uninduced control. Cells with 2K1N and 2K2N 720 
kinetoplast/nucleus configuration were analysed and spindle formation was assessed by 721 
using mouse anti KMX-1 antibody. Graphic bars represent the percentage of cells with 722 
(grey) or without spindle (purple). Error bars, SEM (n>80 cells in each stage). ns not 723 
significant. (B) Ty-mNG-CPC1 expressing parasites were left untreated or treated for 6 724 
hr with 5x EC50 AB1 or 5x EC50 Hesperadin and analyzed by confocal microscopy. Cells 725 
in metaphase and anaphase are shown. Cells were counterstained with DAPI to visualize 726 
DNA (cyan). The right panel shows the Nomarsky (DIC) corresponding images. (C)  727 
Inhibition of Aurora kinase (AUK1) does not affect KKT2 S
508





analyzed by WB in parasites treated or not with 5x EC50 and 729 
2x EC50 Hesperadin for 6 hr and 18 hr respectively. Concurrently, AB1 treatment was 730 
used as positive control in the same conditions. EF-1 alpha protein expression was used 731 
as the loading control. Right: Localization of TY-mNG KKT2 after 6 hr treatment with 732 
5x EC50 Hesperadin. Cells in metaphase are showed. Cells were counterstained with 733 
DAPI to visualize DNA (cyan). (D) Localization of Nucleolar and Spindle Associated 734 
Proteins. Representative fluorescence microscopy micrographs showing localization of 735 
Nucleolar and Spindle Associated Protein 1 (NuSAP1, top panel) and 2 (NuSAP2, lower 736 
panel), after CLK1 inhibition by AB1. Both proteins were endogenously tagged with a 737 
Ty at the N terminus. Cells with 2K1N and 2K2N configuration are shown. Cells were 738 
counterstained with DAPI to visualize DNA (cyan). Lower right panel shows the 739 
quantification in percentage of positive or negative expression of NuSAP2 (n=200) 740 
during anaphase in control (DMSO) or treated (AB1) parasites. Error bars, SEM; ***p < 741 





Figure 5. Regulation of kinetochore assembly by CLK1.  743 
This schematic diagram summarizes the recruitment defects caused by inhibition of 744 
CLK1 by AB1. In untreated cells in metaphase (top panel), CLK1 phosphorylates KKT2, 745 
resulting in recruitment of inner kinetochore components, allowing posterior kinetochore 746 
assembly to outer kinetochore components. When CLK1 is inhibited by AB1 (lower 747 
panel, arrow head), phosphorylation of KKT2 S
508
 is prevented, leading to a failure of 748 
recruitment of inner kinetochore components and consequent cell cycle arrest. We 749 
hypothesize that KKT2 binding to the centromere is compromised (KKT2?) after CLK1 750 
inhibition (dashed circle). H3, histone H3 751 
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 754 
Figure S1. Inner kinetochore core components localization after CLK1 inhibition 755 
(A) Localization of inner kinetochore core components KKT7, KKT11, KKT13, KKT14 756 
and KKT20 after CLK1 inhibition by AB1. Representative fluorescence microscopy 757 
micrographs, showing bloodstream form parasites expressing N-terminal mNeonGreen 758 
(mNG) tagged KKTs. For KKT20, parasites express N-terminal mScarlet (mS) tagged 759 
protein. Cells with 2K1N and 2K2N kinetoplast/nucleus configuration are shown. Cells 760 
were counterstained with DAPI to visualize DNA (cyan). Scale bar, 2µm. (B) Graphic 761 
representation of strategy used for automated identification of kinetochore and 762 
background regions and quantification of fluorescence at kinetochore foci. The region of 763 
parasite body and nucleus is masked in white, and the region of interest (ROI) quantified 764 
for the kinetochore is highlighted with arrows. In this case, KKT2 foci detection in 765 
untreated cells was used as example. (C) The distribution of kinetochore foci, defined as 766 
fluorescence intensities, before and after treatment with AB1. Minima of 60 kinetochore 767 
foci were measured for each condition; individual points are shown as grey dots. Median 768 
(green) and interquartile ranges (IQR) are shown. ** p<0.01, ***p < 0.001.  ns not 769 
significant. (Mann–Whitney U test). (D) Western blots comparing total protein levels of 770 
KKT proteins after 6 hr treatment with AB1 at 5x EC50. EF-1 expression was used as 771 
the loading control.  772 
Figure S2. KKT2 phosphorylation is affected by AB1 773 
KKT2 and KKT3 phosphorylation pattern after AB1 treatment or CLK1 depletion by 774 
RNAi. Phosphorylation pattern of endogenously tagged Ty-mNG KKT2 and Ty-mNG 775 
KKT3 cell lines treated or not with 5x EC50 AB1 for 6 hr, or after 24 hr of CLK1 RNAi 776 
induction. Protein samples were collected and resolved using Phos-tag™ technologies. 777 
Figure S3: Verification of endogenous KKT2 RNAi penetrance throughout strain 778 
generation. (A) Schematic of strain derivatives for selected KKT2 RNAi and recoded 779 
addback strains. (B) Schematic depicting key genetic features of endogenous KKT2 and 780 
recoded KKT2
R
 allowing specific RT-qPCR analysis of endogenous KKT2 mRNA levels. 781 
(C) Results of relative quantitation of endogenous KKT2 mRNA levels in denoted cell 782 
lines by RT-qPCR. Bars and error bars denote mean ± range, n=4, values indicate p-value 783 
results of t-test comparing induced versus non-induced samples (D) Representative 784 
fluorescence microscopy micrographs showing partial mislocalization of recoded 785 
phosphomutant KKT2
S507-508A
, analyzed with anti-HA antibody. Cells with 2K1N and 786 
2K2N kinetoplast/nucleus configuration are shown. Cells were counterstained with DAPI 787 
to visualize DNA (cyan). Scale bar, 2µm. (E) Residue specificity of KKT2 788 




 mutant (arrow). Endogenous mutant expression was analyzed by using anti-HA 790 
antibody. 791 
 792 





(A) Localization and expression pattern of inner kinetochore proteins KKT1 (left) and 794 
KKT9 (right) after expression of recoded catalytically inactive KKT2 R K
113A
. In both 795 
mutants, KKT1 and KKT9 proteins were tagged with mNeonGreen (mNG) at the N 796 
terminus. Cells with 2K1N and 2K2N kinetoplast/nucleus configuration are shown. Cells 797 
were counterstained with DAPI to visualize DNA (cyan). The right panel shows the 798 
Nomarsky (DIC) corresponding images. (B) Representative fluorescence microscopy 799 
micrographs showing localization of inner kinetochore proteins KKT1 (top panel) and 800 
KKT9 (bottom panel) after expression of recoded phosphomimetic KKT2R S
507E
 (left 801 
panel) and KKT2R S
508E
 (right panel). In both mutants, KKT1 and KKT9 proteins were 802 
tagged with mNeonGreen (mNG) at the N terminus. Abnormal nuclear shape after 803 
induction is shown with white arrows. Cells in metaphase and anaphase are shown. Cells 804 
were counterstained with DAPI to visualize DNA (cyan). The right panel shows the 805 
Nomarsky (DIC) corresponding images. Scale bar, 2µm. 806 
Figure S5. MAP103 expression after CLK1 inhibition by AB1  807 
Spindle formation after CLK1 inhibition. Parasites expressing mNG-MAP103 were left 808 
untreated or treated for 6 hr with 5x AB1 and analyzed by confocal microscopy. Error 809 
bars, SEM (n>100 cells in metaphase). ns not significant. lower: representative 810 
micrograph of each condition 811 












Recoded Plasmids. To express catalytically inactive KKT2 and phospho-mutants, the active 
site lysine (K113) and serine (S5, S8, S507-S508 and S828) were changed to alanine by 
mutating pGL2492, carrying the coding sequence for KKT2, using site directed mutagenic 
PCR as follows: 
 
PRIMER SEQUENCES MUTATION PLASMID 
5’- GTTCAATGTCGCGCCAGCGAGTC KKT2R S5A pGL2795 
3’- ATTCTAGATATTTTATGGCAGCAAC 
5’- CTCACCAGCGGCGCGTGACCGCG KKT2R S8A pGL2796 
3’- ACATTGAACATTCTAGATATTTTATGGCAG 
5’- CCCCCGCAGCGCGCTCTCCATGC KKT2R S25A pGL2797 
3’- CGCGGGGTGCGCTGACTC 
5’- AAGGGTCGGTGCAGCATTAAGGCCGC KKT2R S507A-S508A pGL2749 
3’- GTTCCACGTTTGGGCTGTTTT 
5’- TAGACAGAATGCATGCGAGCCTTATGCACC KKT2R S828A pGL2750 
3’- GCTTCGGTTCTGACCCTC 
5’- GTGCGCCTTGGCAGTATCGTCGAAAC KKT2R K113A pGL2850 
3’- AACTCCCCGCCACTTGAC 
5’- AAGGGTCGGTGAATCATTAAGGCCG KKT2R S507E pGL2770 
3’- GTTCCACGTTTGGGCTGT 




Antibody Obtained from 
Mouse Imprint Monoclonal Anti-Ty1 
antibody (clone BB2) 
Sigma Aldrich 
Mouse Anti-HA (clone 12CA5) Roche 
Mouse Anti-EF1α Antibody, (clone CBP-
KK1) 
Merck-Milipore 
Rabbit Anti-phospho KKT2 S508 Invitrogen 
Mouse monoclonal anti-KMX-1  Keith Gull laboratory 
StarBright™ Blue 520 Goat anti-Mouse IgG  BIORAD 




RT-qPCR for validation of KKT2 RNA Knockdown. RNAi inductions were set up to be 
able to collect 2 x 107 trypanosomes at 24h post tetracycline addition. Total RNA was 
extracted from these cell pellets using the NEB Monarch RNA Miniprep kit to 
manufacturer’s instructions. Contaminating gDNA was removed using TURBO DNA-free 
treatment (Invitrogen). One hundred nanograms of total RNA was then used to prime RT-
qPCR reactions set up using Luna Universal One-Step RT-qPCR Kit (NEB), which were 
amplified and measured using the SYBR and ROX channels of an Applied Biosystems 
QuantStudio 3 System machine. Oligonucleotides were designed using Primer-BLAST 
against the 3’ UTR of the KKT2 gene to allow quantification of the WT allele and avoid the 
RNAi stem-loop RNA and the recoded KKT2 allele’s mRNA. Primer efficiencies were 
previously verified to be between 95% and 105% using a standard curve analysis prior to 
relative quantitation experiments. Relative quantitation experiments were performed using 
the ∆∆ct method with the Tb927.10.12970 (C1) as an endogenous control (1). Samples for 
comparison were run in technical quadruplicates. No-reverse transcriptase and no-template 
controls were included on each plate for each sample condition, each in duplicate. Data were 
analysed in the RQ module of ThermoFisher Cloud to perform the relative quantitation 
including the T-test option for comparing induced to non-induced samples. 
KKT2 qPCR Primers 
Oligo Target Gene ID Sequence Description Efficiency 




OL12550 KKT2   
3' UTR 
Tb927.11.10520 5'-CGCTTCTGTGTTCGGGTACT  KKT2 96.70% 
OL12551 3'-AGGTGGTCGGACACTGGATA 
 
Recombinant assays and enzyme purification. Recombinant full-length CLK1 was produced 
as described (22). For KKT2 protein production, the KKT2 (aa 486 - 536) CDS was cloned in 
pET24-MBP-TEV vector, generating the plasmid NITD2500. Recombinant expression was 
carried out by lactose autoinduction in Terrific Broth containing 0.4% glycerol, 0.05% glucose, 
0.05% lactose, 0.05% arabinose and buffered by 100 mM sodium phosphate (pH 7.0). In brief, 
0.7 L of this media was inoculated at 0.1 OD600 with an overnight Luria Broth culture and 
shaken at 37 ̊ C and 250 rpm for 2.5 hr. Then, temperature was lowered to 18 ̊ C and the culture 
was allowed to grow and induced overnight and harvested 20-24 hr later. Cells are pelleted and 
stored at -80 ˚C prior to purification. Cell lysis was done by sonication in an ice bath (20 sec 
ON/OFF, 3 min active sonication at 70-110 watts power) in 40 mL Equilibration Buffer (25 
mM HEPES pH 7.5 300 mM NaCl 5% glycerol 0.5 mM TCEP) and the clarified lysate is 
purified by IMAC on a 5 mL HisTrap column (GE Healthcare). The IMAC elution was further 
purified by sizing on a 300 mL Superdex 200 prep grade column (GE Healthcare) packed in a 
2.6 cm diameter housing. Included volume fractions were pooled and analysed by SDS-PAGE 
or LC-MS.  
To express recombinant KKT2S507-508A, plasmid NITD2500 was mutated using site directed 
mutagenic PCR as follows to give plasmid NITD2501: 
PRIMER SEQUENCES MUTATION PLASMID 
5’- GCGTGTGGGGgcagcaTTGCGCCCGC KKT2 S507-508A NITD2501 
3´- GTCCCACGCTTAGGCTGT 
 
Recombinant CLK1 enzyme activity assays were performed in white 96 well, solid bottom 
plate (GREINER) by triplicate. The assay buffer contained 40 mM Tris (pH 7.5), 20 mM 
MgCl2, 0.1mg/ml BSA and 2 mM DTT. As indicated, kinase reaction contains the enzyme 
CLK1 (3 nM), and 1 micromolar or each indicated substrate. Maltose binding protein (MBP, 
Abcam ab219252) and DMSO were added as control of background or autophosphorylation 
respectively. ATP (10 µM) was added to initiate the reaction. After 25 min reaction at room 
temperature, the ADP-Glo reagent and detection solution was added following the technical 
manual of ADP-GloTM kinase assay kit (Promega). The luminescence was measured on 
CLARIOstar BMG LABTECH microplate reader. 
Kinetochore foci intensity capture and analysis. Cells were imaged using a Zeiss LSM 880 
with Airyscan on an Axio Observer.Z1 inverted confocal microscope. A Plan-Apochromat 
63x/1.4 oil objective lens was used to image 476 x 476 70nm pixels with a photomultiplier 
tube and 16x averaging at 38s/frame. DAPI and mNeonGreen excitation were from 405 and 
488nm lasers with detection wavelengths 416-479nm and 491-589nm respectively. For 
measurement of kinetochore foci intensity, three channel image stacks of mNeonGreen labelled 
kinetochore components in fixed trypanosomes were analyzed using bespoke Matlab software 
(available here https://github.com/awollman). Blue, nuclear stained images were first 
segmented by thresholding using Otsu’s method and applying a series of morphological 
transformations to remove holes and any objects smaller than 300-pixel area. This allowed the 
nucleus to be segmented and removed any detected mitochondria, also stained by DAPI. The 
whole cell was then segmented from the DIC image, using edge detection and similar 
morphological transformation, combined with watershedding, using the nuclear mask as 
‘seeds’ for each cell. Finally, bright foci were detected in the mNeonGreen image using spot 
detection software optimized for detecting and characterizing low intensity foci in noisy 
cellular environments (2, 3). In brief, candidate foci were detected by thresholding and 
Gaussian masking, before their local background corrected intensity was determined and 
accepted if above a threshold based on the standard deviation of local pixel noise. Each detected 
cell was assigned a tracking number and foci categorized into each cell. This allowed for 
manual assignment into cell cycle stage. Fluorescent foci intensity was maintained in the linear 
range by optimizing the Imaging conditions using untreated cells to make the best use of the 
dynamic range of the detector while avoiding saturation. Microscope settings were kept 
constant between samples, and no saturation was detected, ensuring foci remained in the linear 
intensity regime.  
Recombinant assays and enzyme purification. Recombinant full-length CLK1 was produced 
as described (4) For KKT2 protein production, the KKT2 (aa 486 - 536) CDS was cloned in 
pET24-MBP-TEV vector, generating the plasmid NITD2500. Recombinant expression was 
carried out by lactose autoinduction in Terrific Broth containing 0.4% glycerol, 0.05% glucose, 
0.05% lactose, 0.05% arabinose and buffered by 100 mM sodium phosphate (pH 7.0). In brief, 
0.7 L of this media was inoculated at 0.1 OD600 with an overnight Luria Broth culture and 
shaken at 37 ̊ C and 250 rpm for 2.5 hr. Then, temperature was lowered to 18 ̊ C and the culture 
was allowed to grow and induced overnight and harvested 20-24 hr later. Cells are pelleted and 
stored at -80 ˚C prior to purification. Cell lysis was done by sonication in an ice bath (20 sec 
ON/OFF, 3 min active sonication at 70-110 watts power) in 40 mL Equilibration Buffer (25 
mM HEPES pH 7.5 300 mM NaCl 5% glycerol 0.5 mM TCEP) and the clarified lysate is 
purified by IMAC on a 5 mL HisTrap column (GE Healthcare). The IMAC elution was further 
purified by sizing on a 300 mL Superdex 200 prep grade column (GE Healthcare) packed in a 
2.6 cm diameter housing. Included volume fractions were pooled and analysed by SDS-PAGE 
or LC-MS.  
To express recombinant KKT2S507-508A, plasmid NITD2500 was mutated using site directed 
mutagenic PCR as follows to give plasmid NITD2501: 
PRIMER SEQUENCES MUTATION PLASMID 
5’- GCGTGTGGGGgcagcaTTGCGCCCGC KKT2 S507-508A NITD2501 
3´- GTCCCACGCTTAGGCTGT 
 
Recombinant CLK1 enzyme activity assays were performed in white 96 well, solid bottom 
plate (GREINER) by triplicate. The assay buffer contained 40 mM Tris (pH 7.5), 20 mM 
MgCl2, 0.1mg/ml BSA and 2 mM DTT. As indicated, kinase reaction contains the enzyme 
CLK1 (3 nM), and 1 micromolar or each indicated substrate. Maltose binding protein (MBP, 
Abcam ab219252) and DMSO were added as control of background or autophosphorylation 
respectively. ATP (10 µM) was added to initiate the reaction. After 25 min reaction at room 
temperature, the ADP-Glo reagent and detection solution was added following the technical 
manual of ADP-GloTM kinase assay kit (Promega). The luminescence was measured on 
CLARIOstar BMG LABTECH microplate reader. 
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